Emily Parker @911GlobalMeds
18 April, 02:40
LETROZOLE / FEMARA MEDICATION PATIENT INFORMATION IN SWEDISH

Femara minskar mängden östrogen genom att blockera ett enzym ("aromatas") som är involverat i produktionen av östrogener och kan därför blockera tillväxten av bröstcancer som behöver östrogener för attväxa.

Source: https://shorturl.at/fnuFJ

#LetrozoleInformation #FemaraInformation #PatientEducation #SwedishMedication #HealthcareSweden #MedicationGuide #LetrozoleSweden #FemaraSweden #SwedishHealthcare #cancertreatment #breastcancerawareness #SwedishPatientResources

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Carole Parnell donated @MagaMutt
16 April, 09:33
Ivermectin as a ‘Powerful Drug’ for Fighting Cancer: A Look at the Evidence

Now that discussing 𝗶𝘃𝗲𝗿𝗺𝗲𝗰𝘁𝗶𝗻 seems to be allowed again, we take a close look at its off-label use as a potential therapy for cancer.

We also examine Rick Alderson's story, who was diagnosed with terminal colon cancer.

https://ept.ms/CancerTreat...

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
arba happihr @arba
08 April, 08:55

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Emily Parker @911GlobalMeds
08 March, 02:35
Evolving role of zoledronic acid in early breast cancer

Most women diagnosed in the early stages of breast cancer are likely to have a great prognosis. It is also likely that they remain disease free for several years after their treatment ends.

However, the side effects of such treatments associated with bone issues are also likely to have effect the patient's bone health in the long run.

The bone loss associated with breast cancer therapy like endocrine therapy may contribute towards the risk of osteoporosis and bone fractures in the long run.

Several guidelines for treatment are now changed to include the need for preserving bone health in adjuvant therapy regimes and any measures involved.

Source: https://shorturl.at/gnZ68

#BreastCancer
#ZoledronicAcid
#cancertreatment
#MedicalAdvancements
#bonehealth

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Emily Parker @911GlobalMeds
05 March, 04:51
Palbociclib Improves Survival in Women with Breast Cancer

Palbociclib (Brand Ibrance) is a targeted therapy (CDK 4/6 inhibitor) manufactured by Pfizer which is used for the treatment of HER2-negative and HR-positive breast cancer. Ibrance is marketed by Pfizer in India under the Brand name of PALBACE.

Source: https://shorturl.at/rxJV7

#Palbociclib #BreastCancer #cancertreatment #SurvivalRates #medicalresearch #HealthCare #Oncology #WomenHealth #CancerTherapy #clinicaltrials

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.